 |
|
The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
Yeon Woong Chung, Tae Hoon Oh, Sung Kun Chung
Korean J Ophthalmol. 2013;27(3):167-171. Published online 2013 Apr 8 DOI: https://doi.org/10.3341/kjo.2013.27.3.167
|
|
Citations to this article as recorded by
 Ocular Surface Analysis of Dry Eye Disease After Cataract Surgery
Wimolwan Tangpagasit, Onnicha Srivanich
Cornea Open.2024; 3(1): e0027. CrossRef Comparative efficacy of cyclosporine 0.1%, rebamipide 2%, and carboxymethylcellulose-cyclosporine 0.05% combination eye drops in the management of dry eye disease among the Indian population
Abhinav Goyal, Khushboo Bansal
Indian Journal of Clinical and Experimental Ophthalmology.2024; 10(1): 89. CrossRef Evaluation of cyclosporine 0.05% and artificial tears for the management of dry eye disease following cataract surgery: a randomized controlled trial
Hanieh Ahmadi, Saeed Tahmasbian, Maryam Janbazi, Arvin Amiri, Zahra Heidari
Annals of Medicine & Surgery.2024; 86(4): 1983. CrossRef Management of cataract in dry eye disease: Preferred practice pattern guidelines
Pragnya R Donthineni, Rashmi Deshmukh, Chitra Ramamurthy, Virender S Sangwan, Jodhbir S Mehta, Sayan Basu
Indian Journal of Ophthalmology.2023; 71(4): 1364. CrossRef Dry eye and cataract surgery: Narrative review and recommendations for management
Edoardo Villani, Anton Giulio Catania, Saverio Vincenzo Luccarelli, Fabrizio Magnani, Gianluca Martone, Emma Zanzottera, Neil Lagali
European Journal of Ophthalmology.2023; : 112067212311740. CrossRef Exploring the Therapeutic Potential of Cyclosporine for Ophthalmic Indications by Novel Carrier Systems
Garima Rawat, Shital Kolhe, Dhwani Rana, Sagar Salave, Derajram Benival
Critical Reviews™ in Therapeutic Drug Carrier Systems.2023; 40(5): 1. CrossRef Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
Ha Rim So, Jiwon Baek, Ji Young Lee, Hyun Seung Kim, Man Soo Kim, Eun Chul Kim
Annals of Medicine.2023;[Epub] CrossRef Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials
Shuang Liu, Guang Yang, Qingnan Li, Shaohua Tang
Indian Journal of Ophthalmology.2023; 71(4): 1304. CrossRef Occurrence of Corneal Staining after Cataract Surgery with and without Chitosan-N-Acetylcysteine Eye Drops
Stefan Palkovits, Andreas Schlatter, Manuel Ruiss, Stefan Georgiev, Johannes Zeilinger, Caroline Pilwachs, Oliver Findl
Ophthalmic Research.2023; 66(1): 1293. CrossRef Comparison of the Effects of 0.05% and 0.1% Cyclosporine for Dry Eye Syndrome Patients after Cataract Surgery
Heeyong Han, Sangkyung Choi
Journal of the Korean Ophthalmological Society.2023; 64(11): 987. CrossRef Evaluation of effects of 3% diquafosol ophthalmic solution on preocular tear film stability after trabeculectomy
Qian Liu, Wenjun Cheng, Changgeng Liu, Xin Jin, Shuai Ming, Duo Zhao, Xiaomei Feng
International Ophthalmology.2022; 43(6): 1903. CrossRef Efficacy of 0.05% cyclosporine A on the lipid layer and meibomian glands after cataract surgery: A randomized, double-masked study
Min Seung Kang, Jonghoon Shin, Jeong Min Kwon, Jin Huh, Ji Eun Lee, Meng C. Lin
PLOS ONE.2021; 16(1): e0245329. CrossRef Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome
Soledad Retamozo, Chiara Baldini, Hendrika Bootsma, Salvatore De Vita, Thomas Dörner, Benjamin A. Fisher, Jacques-Eric Gottenberg, Gabriela Hernández-Molina, Agnes Kocher, Belchin Kostov, Aike A. Kruize, Thomas Mandl, Wan-Fai Ng, Raphaèle Seror, Yehuda Sh
Drugs & Aging.2021; 38(4): 265. CrossRef Cataract Surgery Destabilises Temporary the Tear Film of the Ocular Surface
Le Xuan Cung, Nguyen Thi Thanh Nga, Duong Mai Nga, Nguyen Xuan Hiep, Duy Thoai Pham
Klinische Monatsblätter für Augenheilkunde.2021; 238(03): 282. CrossRef A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery
Sangyoon Kim, Jonghoon Shin, Ji Eun Lee
Scientific Reports.2021;[Epub] CrossRef Assessment of the Compliance with 0.1% Cyclosporine A in Dry-Eye Patients with Sjögren's Syndrome
Do Hee Park, Hyung Nam Jin, Hee Su Yoon, Hyeon Jeong Yoon, Kyung-Chul Yoon
Journal of the Korean Ophthalmological Society.2021; 62(7): 895. CrossRef Topical cyclosporine A for the treatment of dry eye: a randomized clinical study
InjyY ElShazly, MahmoudH Morsy, AdnanA Bekhit, AlyaaA Ramadan, EhabF Mossallam
Delta Journal of Ophthalmology.2021; 22(3): 165. CrossRef Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms
Carlo Cagini, Giampiero Di Lascio, Giovanni Torroni, Marco Mariniello, Giulia Meschini, Marco Lupidi, Marco Messina
Journal of Cataract and Refractive Surgery.2021; 47(11): 1430. CrossRef Changes in Tear Osmolarity and Matrix Metalloproteinase-9 Relative to Ocular Discomfort after Femtosecond Laser-Assisted Cataract Surgery
Kyu Sang Eah, Hun Lee, Jae Yong Kim, Hungwon Tchah
Applied Sciences.2021; 11(24): 11878. CrossRef Effects of preoperative doses of betamethasone acetate 0.1% on dry eye control after cataract surgery
Saeed Shokoohi-Rad, SeyedehZeinab Hashemi Javaheri, FatemehZare Malekabad, Hamid Khakshoor, MohammadKhajeh Daluee
Indian Journal of Ophthalmology.2020; 68(3): 450. CrossRef Cataract surgery and dry eye disease: A review
Khayam Naderi, Jack Gormley, David O’Brart
European Journal of Ophthalmology.2020; 30(5): 840. CrossRef Management of dry eye disease to optimize cataract surgery outcomes: Two tables for a daily clinical practice
M. Labetoulle, A. Rousseau, C. Baudouin
Journal Français d'Ophtalmologie.2019; 42(8): 907. CrossRef Topical Cyclosporine (0.05%) for Management of Dry Eyes in Patients Undergoing Cataract Surgery-A Comparative Study
Sri Ganesh, Sheetal Brar, Sheetal N. Bagare
The Open Ophthalmology Journal.2019; 13(1): 34. CrossRef Effectiveness of Cyclosporine-steroid Treatment after Cataract Surgery according to Dry Eye Severity
Jae Yeong Park, Sang Cheol Yang, Young Min Park, Ji Eun Lee, Choul Yong Park, Jong Soo Lee
Journal of the Korean Ophthalmological Society.2019; 60(9): 821. CrossRef Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study
Shaveta Singla, Lopamudra Sarkar, Mukesh Joshi
Taiwan Journal of Ophthalmology.2019; 9(3): 173. CrossRef Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial
Ikhyun Jun, Seonghee Choi, Geun Young Lee, Young Joon Choi, Hyung Keun Lee, Eung Kweon Kim, Kyoung Yul Seo, Tae-im Kim
Scientific Reports.2019;[Epub] CrossRef Topical cyclosporine A therapy for dry eye syndrome
Cintia S de Paiva, Stephen C Pflugfelder, Sueko M Ng, Esen K Akpek
Cochrane Database of Systematic Reviews.2019;[Epub] CrossRef Management of Postoperative Inflammation and Dry Eye After Cataract Surgery
Kumiko Kato, Kensaku Miyake, Koji Hirano, Mineo Kondo
Cornea.2019; 38(1): S25. CrossRef Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye
Lian Cui, Ying Li, Hyo Seok Lee, Jee Myung Yang, Won Choi, Kyung Chul Yoon
International Ophthalmology.2018; 38(5): 2021. CrossRef Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome
Hyun Seung Kim, Tae-im Kim, Jin Hyoung Kim, Kyung Chul Yoon, Joon Young Hyon, Ko Un Shin, Chul Young Choi
Journal of Ocular Pharmacology and Therapeutics.2017; 33(7): 530. CrossRef Safety and Efficacy of an Artificial Tear Containing 0.3% Hyaluronic Acid in the Management of Moderate-to-Severe Dry Eye Disease
Alberto López-de la Rosa, José Pinto-Fraga, Francisco Blázquez Arauzo, Rubén Urbano Rodríguez, María J. González-García
Eye & Contact Lens: Science & Clinical Practice.2017; 43(6): 383. CrossRef Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease
José Pinto-Fraga, Alberto López-de la Rosa, Francisco Blázquez Arauzo, Rubén Urbano Rodríguez, María J. González-García
Eye & Contact Lens: Science & Clinical Practice.2017; 43(1): 57. CrossRef TFOS DEWS II iatrogenic report
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Nathan Efron, Masatoshi Hirayama, Jutta Horwath-Winter, Terry Kim, Jodhbir S. Mehta, Elisabeth M. Messmer, Jay S. Pepose, Virender S. Sangwan, Alan L. Weiner, Steven E. Wilson, James S. Wolffsohn
The Ocular Surface.2017; 15(3): 511. CrossRef Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat, Frank S. Hwang
Expert Review of Ophthalmology.2017; 12(4): 269. CrossRef A COMPARATIVE STUDY OF TEAR FILM PARAMETERS BEFORE AND AFTER SMALL INCISION CATARACT SURGERY AND PHACOEMULSIFICATION
Anubhav Baveja, Nitin Batra
Journal of Evidence Based Medicine and Healthcare.2017; 4(26): 1510. CrossRef Transient Tear Film Dysfunction after Cataract Surgery in Diabetic Patients
Donghong Jiang, Xiangqian Xiao, Tongsheng Fu, Alireza Mashaghi, Qinghuai Liu, Jiaxu Hong, Fu-Shin Yu
PLOS ONE.2016; 11(1): e0146752. CrossRef Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
Jang Hoon Lee, In Seok Song, Kyoung Lae Kim, Sam Young Yoon
Journal of Ophthalmology.2016; 2016: 1. CrossRef Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study
Ke Yao, Yongzhen Bao, Jian Ye, Yi Lu, Hongsheng Bi, Xin Tang, Yune Zhao, Jinsong Zhang, Jinling Yang
BMC Ophthalmology.2015;[Epub] CrossRef The course of dry eye after phacoemulsification surgery
Servet Cetinkaya, Emine Mestan, Nursen Oncel Acir, Yasemin Fatma Cetinkaya, Zeynep Dadaci, Halil Ibrahim Yener
BMC Ophthalmology.2015;[Epub] CrossRef Fluorescein-Tear Breakup Time as an Assessment of Efficacy of Tear Replacement Therapy in Dry Eye Patients: A Systematic Review and Meta-Analysis
Michael J. Doughty
The Ocular Surface.2014; 12(2): 100. CrossRef Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract Surgery
Kyung Eun Han, Sang Chul Yoon, Ji Min Ahn, Sang Min Nam, R. Doyle Stulting, Eung Kweon Kim, Kyoung Yul Seo
American Journal of Ophthalmology.2014; 157(6): 1144. CrossRef Cataract surgery in patients with ocular surface disease: An update in clinical diagnosis and treatment
Neda Afsharkhamseh, Asadolah Movahedan, Hooman Motahari, Ali R. Djalilian
Saudi Journal of Ophthalmology.2014; 28(3): 164. CrossRef Effect of Cyclosporin A on Tear Film and Corneal Aberration after Cataract Surgery
Jei Hun Jeon, Hong Seok Kim, Ji Won Jung, Sang Chul Yoon, Kyoung Yul Seo, Hyung Keun Lee, Eung Kweon Kim, Tae Im Kim
Journal of the Korean Ophthalmological Society.2014; 55(7): 978. CrossRef Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
Clyde Schultz
Ophthalmology and Eye Diseases.2014; 6: OED.S16067. CrossRef Topical cyclosporine: are all indications justified?: Table 1
Pasquale Aragona
British Journal of Ophthalmology.2014; 98(8): 1001. CrossRef
|